Background
==========

Conjugated linoleic acid (CLA) is a wide term which groups together a mixture of positional and geometric isomers of C 18:2 fatty acids having conjugated, or contiguous, double bounds. These fatty acids arise along the ruminal process which ends with full saturation into stearic acid, a stepped pathway carried out by rumen bacteria.

These naturally occurring groups of dienoic derivatives of linoleic acid are incorporated into the fat in beef and milk of ruminants before the saturation process has been completed. Numerous beneficial effects are attributed to CLA, as in slowing down or even preventing tumor development. CLA decreases body fat storage in animal models \[[@B1]\] and promotes cardiovascular protection against atheroesclerosis \[[@B2]\]. A growing bulk of evidence shows that CLA, mainly as *cis*-9, *trans*-11, 18:2 n-6 derivatives, consistently produced antitumor effects, thus reducing the incidence, progression, number of metastases and tumor burden in rats and in murine models of mammary gland, colon, forestomach, skin and prostate tumorigenesis \[[@B3]\]. The evidence became so convincing that the National Academy of Science advised in 1996 that \"Conjugated linoleic acid (CLA) is the only fatty acid shown unequivocally to inhibit carcinogenesis in experimental animals\" \[[@B4]\]. Beside CLA, other polyunsaturated fatty acids (PUFA) belonging to the essential fatty acid (EFA) n-3 family, whose main source are fish and seafood, are generally believed to act as antipromoters for several cancers.

Interestingly enough for those populations having little o negligible fish intake as in the case of the mediterranean population of Argentina \[[@B5],[@B6]\], CLA remains the only source of beneficial fatty acids with respect to tumor prevention and cardiovascular protection.

The natural source of CLA are red meats and fatty dairy products, which are mainly bovine derivatives. However, these foods are also heavily suspected to be related to the higher risk of developing colorectal cancer (CRC) in humans. Indeed, as a consequence of a huge, and often contradictory, epidemiological, clinical and experimental amount of research, general advice has been sent to the population at large, suggesting that fatty beef, and to a lesser extent, whole fatty dairy derivatives, should be eaten less frequently, whereas the amount of dietary n-3 PUFAs might be increased.

CRC in humans continues to be a major challenge, since death rates due to colon carcinoma have not diminished appreciably within the past decades \[[@B7]\]. CRC is a major disease in Western populations, and diet may account for approximately 35% of the cases. The Argentinean food pattern, rich in beef and fats and poor in fibres and fish, may be related to an increased CRC risk. Our previous case-control studies on Argentinian people were consistent with these mentioned beliefs, showing that a high frequency of heavily roasted meat was associate with increased CRC risk. Saturated fatty acids and cholesterol also seemed to play an important role in this risk \[[@B8]\]. However, further characterization of meat consumption and risk for CRC by total intake as well as by different varieties of meat showed an unexpected dual behaviour related to the type of meats. Fatty meat derivatives, such as cold cuts and sausages, mainly prepared from fatty beef were consistently associated with higher risk, whereas high consumption of lean beef behaved as a protective dietary habit. High total meat consumption was not related to an increased risk of CRC in our subjects, even adjusting for energy and all macronutrients. Even though that the CRC risk has been attributed to other factors, as amount and varieties of nitrosocompounds \[[@B9]\] and heme ring of hemoglobin \[[@B10]\], several extensive reviews point to an increased risk linked somewhere to meat fat content. Indeed, different kinds of meat have similar levels of protein, so the mayor difference may lay in other components, for example, the amount and quality of lipid components. High fat diets, rich in cholesterol and saturated lipids, may favour cancer because of their high caloric content, or they could lead to increased levels of bile acids in the colonic rumen or a disbalance of the essential fatty acids metabolism \[[@B11]\].

On the other hand, fats from bovine milk and meat contain variable proportions of CLA. Interestingly, CLA is located in the interstitial, non-visible, fat evenly distributed along muscle fibres as well as in subcutaneous depots. Whereas the visible fat may be easily discarded and not consumed during the meal, interstitial fats will be eaten. The remaining invisible intramuscular total fat in lean meats range from 25 to 50 g/Kg (2.5--5%) \[[@B12]\]. As a consequence, beneficial effects of minor amounts of CLA will be relatively enhanced in lean meat compared to fatty meat sub-products since the latter contain thus a substantial amount of saturated fatty acids and cholesterol, as in cold cuts and cow viscera, diluting CLA.

In conclusion, whatever the beneficial or deleterious effects of CLA and saturated fatty acids/cholesterol mechanisms are, in the ruminant meats mixed natural fats may modulate opposite effects with regard to the risk of development of CRC in humans, according to their relative concentrations.

Presentation of the hypothesis
==============================

The aim of this review is to analyse the evidence demonstrating that reciprocal proportions of CLA and saturated fats/cholesterol may play an antagonistic role producing contradictory or no effects, as in the case of beef meat and dairy product intake with regard to risk of colon cancer.

Relative proportions of CLA and saturated fats/cholesterol in lean and fatty beefs meat
---------------------------------------------------------------------------------------

CLA concentrations in dairy products typically range from 2.9 to 8.92 mg/g fat, of which the 9-*cis*, 11-*trans*isomer makes up to 73 to 93% of the total CLA. Low concentrations of CLA are found in human blood and tissues \[[@B13]\]. The ratio between CLA and saturated fats *plus*cholesterol in fatty and lean meats, is shown in table [1](#T1){ref-type="table"}\[[@B14]\].

###### 

Proportions of Total fats, saturated fats *plus*cholesterol with respect to CLA in fatty or lean beef.

  MEATS   TF      S F A   CH      CLA    CLA/ SFA + CH
  ------- ------- ------- ------- ------ ---------------
  LEAN    15.40   6.52    0.065   0.62   0.09
  FATTY   37.40   15.82   0.09    0.12   0.007

Total fats (TF); Saturated fats (SFA); Cholesterol (CH); Conjugated linoleic acid (CLA) expressed as g of the lipid/100 g of meats, taken from reference \[[@B14]\]. Values of CLA were expressed as averages from data of Ma DW et al \[[@B15]\].

The levels of CLA in commercial beef (g) and dairy products (ml) ranged from 1.2 and 6.2 mg/g of fat and 0.001 -- 4.3 mg/g respectively \[[@B15]\]. The Argentinian people eat an average of 270 g of beef and beef derivatives *per day*. This means roughly a daily consumption of almost 1 g of CLA *per*day, possibly at levels of CLA which may exhibit beneficial health effects according to the literature. It can also be assumed that these minor amounts of CLA should balance the huge amount of dietary saturated fatty acids and cholesterol from beef and other sources of animal fat. As it can be seen, in Table [1](#T1){ref-type="table"}, lean meat has a ratio which is double that of fatty meat.

Mechanism underlying the of action of CLA and saturated fats: CLA, Pro-oxidant or anti-oxidant?
-----------------------------------------------------------------------------------------------

Pioneering studies about the mechanisms involved in the antitumor potential of CLA stated that these fatty acids had strong antioxidant activities. *In vitro*research has suggested that CLA anticancer activity might be partially mediated by inducing lipid peroxidation \[[@B16]\].

The evidence supports the potential role of antioxidant agents in cancer prevention since they are scavengers for organic free radicals and so prevent the tissue damage. Although epidemiologic studies are not entirely consistent, many show an inverse relationship between dietary intake or blood levels of antioxidants contained in foods and cancer risk \[[@B17]\].

Dietary modifications of cattle forage. Influence of CLA, PUFAs and saturated fats levels on ruminant lipid tissues
-------------------------------------------------------------------------------------------------------------------

The *cis*-9, *trans*-11 isomer is the principal dietary form of CLA, but the concentrations of this isomer and the *trans*-10, *cis*-12 isomer in dairy products or beef vary depending on the diet offered to cows or steers, respectively \[[@B18]\].

Decreasing the proportion of manipulated concentrates in the diet of steers, along with increased grass intake caused a desirable decrease in the concentration of intramuscular saturated fatty acid (SFA) and in the n-6 /n-3 PUFA ratio, together with an increase in the PUFA:SFA ratio and CLA concentration. The data indicate that intramuscular fatty acid composition of beef can be improved for healthy human nutrition by replacing manufactured food supplements by natural grass in the diet \[[@B19]\]. In non-ruminants, such as rodents, dietary CLA supplementation significantly reduced energy intake, growth rate, adipose depot weight and carcass lipid content independent of other dietary lipids. Overall, the reduction of adipose depot weight ranged from 43 to 88% \[[@B20]\].

Dietary fatty acid sources also affect CLA concentrations in milk from lactating cows. CLA concentration in milk fat can be enhanced by the addition of polyunsaturated fatty acid (PUFA) to the diet, especially oils high in 18:2 n-6 \[[@B21]\]. Diets rich in 18:3 n-3 can increase the CLA content in milk when dietary sources of this oil are accessible to the rumen microorganisms \[[@B22]\].

Experimental models
-------------------

CLA behaves as a powerful anticarcinogen in a rat tumor model with an effective range as low as 0.5% in the diet. F344 rats were initiated with the carcinogen 2-amino-3-methylimidazol \[4,5-f\] quinolone (IQ) in order to induce colon carcinogenesis. CLA was administered to male rats by gavages followed by IQ. Aberrant crypt foci (ACF) were quantified in colon glands. While CLA administration had no impact on the size of ACF, their number was significantly reduced in the CLA group \[[@B23]\]. Interestingly, the protective effect of CLA is expressed at concentrations close to human consumption levels \[[@B24]\].

Other experimental evidence shows that dietary CLA inhibits azoxymethane-induced colonic aberrant crypt foci in male rats. The administration of CLA caused a significant reduction in the frequency of ACF. Also, these mixtures of *trans*isomers lowered the proliferating cell nuclear antigen (PCNA) index in colonic ACF whereas apoptosis occurred in the cells of ACF \[[@B25]\]. Park et al reported that dietary CLA can inhibit 1.2-dimethylhydrazine-induced colon carcinogenesis by a mechanism probably involving increased apoptosis. These authors suggested a possible chemopreventive activity of CLA in the early phase of colon tumorigenesis through modulation of cryptal cell proliferation activity and apoptosis \[[@B26]\]. As shown, the beneficial effects of CLA as antitumor food are observed for a broad range of chemical carcinogens.

In vitro assay
--------------

Several studies have demonstrated *in vitro*anticancer activity for CLA, with this being cytotoxic to human malignant melanoma, breast, lung and colorectal cancer cell lines \[[@B27]\]. The incubation with CLA showed a significant reduction in the proliferation of colorectal cell HT-29 compared to control cultures \[[@B28]\]. CLA has shown inhibitory effects in cellular growth suppression of human SW480 colon cancer cells and breast cancer MCF-7, being CLA preferentially incorporated into the phospholipid fraction of the MCF-7 cell lipids. The increase in lipid peroxidation observed in CLA-treated cells suggests that CLA may reverse the resistance to the oxidative stress characteristic of cancer cells.\[[@B29]\]

Clinical and epidemiological approaches
---------------------------------------

There is insufficient evidence from human epidemiological data to form a useful guide for nutritional recommendations. Very few of the animal studies have shown a dose-response relationship to the amount of CLA fed and the extent of tumor growth. Development of CRC has been suggested to be closely related to environmental exposure, especially that arising from the diet \[[@B30]\]. Experimental studies in animals and research on human beings have demonstrated that an increase of body fat mass is linked to increased risk of CRC. Obesity has been associated with an increased risk of cancer at a number of sites, including endometrium, postmenopausal breast cancer, pancreas, prostate and colon. There is strong evidence that a high risk of CRC is associated with obesity together other factors including and with a low intake of vegetables, whole grain cereals and fish \[[@B31]\]. It is also possible that one of the antitumoral effects adscribed to CLA may be linked to its capability of weight reduction.

Epidemiological studies suggest that whole milk and derived milk products, rich in CLA, fit well into a healthy eating pattern because CLA, besides its antitumor properties, is hypolipidaemic and antioxidative and is therefore an antiatherosclerotic nutrient \[[@B32]\].

Other anticarcinogens such as butyric acid, sphingomyelin, ether lipids and metabolites of tumor supressor lipids are also present in milk fat, and these may act in conjunction with CLA, thus making the consumption of whole milk and dairy derivatives beneficial \[[@B33]\].

Implications of the hypothesis
==============================

CLA-enriched milk fats may be used on a larger scale to produce CLA-enriched products, such as milk, butter, cheese and yoghurt. Consumption of such natural products may produce a natural chemopreventive effect, without the additional cost of oral supplements or the need for disturbing dietary changes \[[@B27],[@B34]\].

In conclusion, the challenge for nutritionists, physicians and dairy product producers is to improve the quality of healthy meat and milk derivatives, thereby obtaining lower levels of saturated fats and cholesterol, along with desirably higher levels of CLA and n-3 PUFAS. This task is challenging since taste and flavour must be maintained at acceptable levels.
